Amol Dhamane
About Amol Dhamane
Amol Dhamane is the Director of Health Economics & Outcomes Research at Bristol Myers Squibb in Greater New York City Area, with over a decade of experience in the field.
Title
Amol Dhamane is currently the Director of Health Economics & Outcomes Research at Bristol Myers Squibb. He operates out of the Greater New York City Area.
Previous Positions at Boehringer Ingelheim
Amol Dhamane served as Product Director, Health Economics & Outcomes Research at Boehringer Ingelheim from 2013 to 2017. In this role, he worked in the Greater New York City Area, contributing his expertise in health economics and outcomes research.
Previous Role at Xcenda
At Xcenda, Amol Dhamane was Manager of Global Health Economics & Outcomes Research from 2010 to 2013. His tenure involved working on global health economics projects and took place in the Tampa/St. Petersburg, Florida Area.
Early Career and Education
Amol Dhamane started his career as an intern in Global Health Outcomes at GlaxoSmithKline in 2009, based in Research Triangle Park, NC. He also worked as a Research Assistant at the University of Arkansas for Medical Sciences from 2007 to 2009. His educational background includes an M.S. in Pharmaceutical Sciences, Pharmaceutical Evaluation, and Policy (PEP) from the University of Arkansas for Medical Sciences, earned between 2007 and 2009. He also holds a B.Pharm from Savitribai Phule Pune University, completed from 2003 to 2007.
Experience in Health Economics & Outcomes Research
With over a decade of experience in Health Economics & Outcomes Research (HEOR), Amol Dhamane has a diverse background in both pharmaceutical and academic research settings. He has progressively transitioned from a research assistant role to a director position, reflecting his significant expertise and contributions to the field.